Biomarkers

Biomarkers that can enable better diagnosis and prognosis and help identify appropriate treatment options.

 

Antigenome Signatures

The goal of this study is to identify autoantigen signatures to understand and predict multiple sclerosis pathogenesis and also patient responses to interferon beta-1a therapy

Partner: Tedder, Duke University; Bennett, University of Colorado

Status: Complete

Antigenome Signatures Study Description Antigenome Signatures Study Description
Antigenome Signatures Study Description
Antigenome Signatures Study Description
View

Poster presented at ECTRIMS 2023 Poster presented at ECTRIMS 2023
Poster presented at ECTRIMS 2023
Poster presented at ECTRIMS 2023
View

 

Immunome Pilot

This study aims to examine the T cells, B cells, and innate immune cells of people with MS to describe age-related changes and compare them against people without MS

Partner: Bar-Or, Univ. of Pennsylvania

Status: Complete

Immunome Pilot Study Description Immunome Pilot Study Description
Immunome Pilot Study Description
Immunome Pilot Study Description
View

Poster presented at ECTRIMS 2020 Poster presented at ECTRIMS 2020
Poster presented at ECTRIMS 2020
View
Manuscript doi: 10.1016/j.ebiom.2022.104179

Zuroff L, Rezk A, Shinoda K, et al. Immune aging in multiple sclerosis is characterized by abnormal CD4 T cell activation and increased frequencies of cytotoxic CD4 T cells with advancing age. EBioMedicine. 2022;82. doi:10.1016/j.ebiom.2022.104179

 

 

DISCOMS Extension

This study aims to provide data on the durability of disease inactivity, and potential risks, after discontinuing DMT(s) in MS

Partner: Cutter, University of Alabama; Corboy, University of Colorado

Status: Complete

DISCOMS Extension Study Description DISCOMS Extension Study Description
DISCOMS Extension Study Description
DISCOMS Extension Study Description
View

Poster presented at ECTRIMS 2023 Poster presented at ECTRIMS 2023
Poster presented at ECTRIMS 2023
Poster presented at ECTRIMS 2023
View

 

MRF Pilots X 3

This pilot program will develop assays to isolate and define extracellular vesicles (EVs) as biomarkers for specific CNS cell populations and assess EVs as markers for CNS remyelination and repair

MRF Pilot Grant 1: This study aims to identify biomarkers related to neurodegeneration in MS by measuring levels of multiple synaptic proteins in plasma-derived neuronally-enriched exosomes

Partner: Bhargava, Johns Hopkins University

Status: Complete

 

MRF Pilot Grant 2: This study aims to determine if extracellular vesicles (EVs) may serve as biomarkers for chronic active, Rim+ lesions that are associated with more aggressive disease progression and poorer clinical outcomes in patients with MS

Partner: Linden, Weill Cornell Medicine

Status: Complete

 

MRF Pilot Grant 3: This study aims to explore whether 24 weeks of aerobic exercise promotes remyelination in the white matter or chronic MS lesions of patients with MS, and to explore the relationships between demyelination in the brain and EV profiles in MS

Partner: Rooney, Wooliscroft, OHSU

Status: Ongoing

MRF Pilots Study Description MRF Pilots Study Description
MRF Pilots Study Description
MRF Pilots Study Description
View

 

MS Brain Bank Harmonization

This study aims to explore mechanisms related to the general brain atrophy seen in MS by assembling a collection of frozen neocortical samples from 6 brain banks into a single dataset with harmonized phenotypic information and a coherent set of proteomic data

Partner: De Jager, Columbia University

Status: Ongoing

MS Brain Bank Harmonization Study Description MS Brain Bank Harmonization Study Description
MS Brain Bank Harmonization Study Description
MS Brain Bank Harmonization Study Description
View

Poster presented at ECTRIMS 2021 Poster presented at ECTRIMS 2021
Poster presented at ECTRIMS 2021
View

 

CMSC X 4

The CMSC pilot research projects aim to support unique, novel ideas with the potential to help improve MS patient outcomes and quality of health.

 

1. Examining Patterns and Correlates of Wellness in Persons With Multiple Sclerosis Who Use Wheelchairs: This epidemiological study aims to examine the distribution and prevalence of health care behaviors, and their association with wellness outcomes, in a sample of wheelchair users with MS across the US

Partner: Silveira, University of North Texas

Status: Complete

 

2. Immunological and MRI Correlates of Mindfulness-based Stress Reduction (MBSR) in MS: This study aims to examine the psychological, biological, and neuroarchitectural changes associated with Mindfulness-based Stress Reduction (MBSR) in people with MS

Partner: Hemond, University of Massachusetts

Status: Ongoing

 

3. MRI in Pediatric MOG Syndrome: This study aims to use new MRI techniques to differentiate between MS and MOG-associated disease in pediatric patients

Partner: Waubant, University of California, San Francisco

Status: Complete

 

4. Understanding Psychiatric Comorbidity in Multiple Sclerosis Using Genomics

Partner: Kowalec, University of Manitoba

Status: Complete

1. Examining Patterns and Correlates ... 1. Examining Patterns and Correlates ...
1. Examining Patterns and Correlates ...
1. Examining Patterns and Correlates ...
View

2. Immunological and MRI Correlates ... 2. Immunological and MRI Correlates ...
2. Immunological and MRI Correlates ...
2. Immunological and MRI Correlates ...
View

3. MRI in Pediatric MOG Syndrome ... 3. MRI in Pediatric MOG Syndrome ...
3. MRI in Pediatric MOG Syndrome ...
3. MRI in Pediatric MOG Syndrome ...
View